Key facts
- HealthLeap’s last known valuation is $205.5M (Feb 2026).
- It has raised $38.2M; the latest was Early Stage VC ($30.0M) in Feb 2026.
- Notable investors include Fifty Years, Hummingbird Ventures, Cedars-Sinai Accelerator.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for HealthLeap
- ·The full record, as it builds
Funding rounds
No funding rounds for HealthLeap are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About HealthLeap
Developer of an artificial intelligence-driven clinical decision support platform designed for patient risk identification and malnutrition management. The company's platform utilizes machine learning algorithms to conduct continuous, automated analysis of inpatient health data and automated coding assistance for accurate acuity documentation, enabling hospital systems to identify high-risk patients through improved diagnostic accuracy and resource allocation.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2022
- Employees
- 16
- Website
- healthleap.ai/
- Ownership
- Privately Held (backing)
HealthLeap doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HealthLeap shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HealthLeap in its N-PORT filings yet. We sweep new filings monthly.